447 related articles for article (PubMed ID: 28924743)
1. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
Dallmann A; Ince I; Coboeken K; Eissing T; Hempel G
Clin Pharmacokinet; 2018 Jun; 57(6):749-768. PubMed ID: 28924743
[TBL] [Abstract][Full Text] [Related]
2. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
[TBL] [Abstract][Full Text] [Related]
3. A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4.
Gaohua L; Abduljalil K; Jamei M; Johnson TN; Rostami-Hodjegan A
Br J Clin Pharmacol; 2012 Nov; 74(5):873-85. PubMed ID: 22725721
[TBL] [Abstract][Full Text] [Related]
4. Human plasma concentrations of cytochrome P450 probe cocktails extrapolated from pharmacokinetics in mice transplanted with human hepatocytes and from pharmacokinetics in common marmosets using physiologically based pharmacokinetic modeling.
Utoh M; Suemizu H; Mitsui M; Kawano M; Toda A; Uehara S; Uno Y; Shimizu M; Sasaki E; Yamazaki H
Xenobiotica; 2016 Dec; 46(12):1049-1055. PubMed ID: 26916082
[TBL] [Abstract][Full Text] [Related]
5. Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children.
Zhou W; Johnson TN; Bui KH; Cheung SYA; Li J; Xu H; Al-Huniti N; Zhou D
Clin Pharmacol Ther; 2018 Jul; 104(1):188-200. PubMed ID: 29027194
[TBL] [Abstract][Full Text] [Related]
6. A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.
De Sousa Mendes M; Lui G; Zheng Y; Pressiat C; Hirt D; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Urien S; Benaboud S
Clin Pharmacokinet; 2017 May; 56(5):537-550. PubMed ID: 27766562
[TBL] [Abstract][Full Text] [Related]
7. Development of a Physiologically Based Pharmacokinetic Model to Predict Disease-Mediated Therapeutic Protein-Drug Interactions: Modulation of Multiple Cytochrome P450 Enzymes by Interleukin-6.
Jiang X; Zhuang Y; Xu Z; Wang W; Zhou H
AAPS J; 2016 May; 18(3):767-76. PubMed ID: 26961818
[TBL] [Abstract][Full Text] [Related]
8. Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.
Alsmadi MM; Idkaidek N
Curr Drug Metab; 2018; 19(12):972-978. PubMed ID: 29962340
[TBL] [Abstract][Full Text] [Related]
9. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy.
Abduljalil K; Pansari A; Jamei M
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):361-383. PubMed ID: 32840724
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
Walzer M; Bekersky I; Blum RA; Tolbert D
Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
[TBL] [Abstract][Full Text] [Related]
11. Human plasma concentrations of five cytochrome P450 probes extrapolated from pharmacokinetics in dogs and minipigs using physiologically based pharmacokinetic modeling.
Shida S; Yamazaki H
Xenobiotica; 2016 Sep; 46(9):759-64. PubMed ID: 26652678
[TBL] [Abstract][Full Text] [Related]
12. Human plasma concentrations of cytochrome P450 probes extrapolated from pharmacokinetics in cynomolgus monkeys using physiologically based pharmacokinetic modeling.
Shida S; Utoh M; Murayama N; Shimizu M; Uno Y; Yamazaki H
Xenobiotica; 2015; 45(10):881-6. PubMed ID: 26075833
[TBL] [Abstract][Full Text] [Related]
13. Model qualification of the PK-SimĀ® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
Yun YE; Edginton AN
J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
[TBL] [Abstract][Full Text] [Related]
14. The Constraints, Construction, and Verification of a Strain-Specific Physiologically Based Pharmacokinetic Rat Model.
Musther H; Harwood MD; Yang J; Turner DB; Rostami-Hodjegan A; Jamei M
J Pharm Sci; 2017 Sep; 106(9):2826-2838. PubMed ID: 28495566
[TBL] [Abstract][Full Text] [Related]
15. A simplified PBPK modeling approach for prediction of pharmacokinetics of four primarily renally excreted and CYP3A metabolized compounds during pregnancy.
Xia B; Heimbach T; Gollen R; Nanavati C; He H
AAPS J; 2013 Oct; 15(4):1012-24. PubMed ID: 23835676
[TBL] [Abstract][Full Text] [Related]
16. Effects of aging and rifampicin pretreatment on the pharmacokinetics of human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol and midazolam in common marmosets genotyped for cytochrome P450 2C19.
Toda A; Uehara S; Inoue T; Utoh M; Kusama T; Shimizu M; Uno Y; Mogi M; Sasaki E; Yamazaki H
Xenobiotica; 2018 Jul; 48(7):720-726. PubMed ID: 28686070
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs.
Mogi M; Toda A; Iwasaki K; Kusumoto S; Takehara H; Shimizu M; Murayama N; Izumi H; Utoh M; Yamazaki H
J Toxicol Sci; 2012; 37(6):1157-64. PubMed ID: 23208431
[TBL] [Abstract][Full Text] [Related]
18. Physiologically Based Pharmacokinetic (PBPK) Model Predictions of Disease Mediated Changes in Drug Disposition in Patients with Nonalcoholic Fatty Liver Disease (NAFLD).
Adiwidjaja J; Spires J; Brouwer KLR
Pharm Res; 2024 Mar; 41(3):441-462. PubMed ID: 38351228
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs.
Han YL; Li D; Ren B; Jing GP; Meng XL; Zhou ZY; Yu Q; Li Y; Wan LL; Guo C
J Ethnopharmacol; 2012 Jan; 139(1):104-9. PubMed ID: 22079696
[TBL] [Abstract][Full Text] [Related]
20. Use of Physiologically Based Pharmacokinetic Modeling for Hepatically Cleared Drugs in Pregnancy: Regulatory Perspective.
Coppola P; Kerwash E; Cole S
J Clin Pharmacol; 2023 Jun; 63 Suppl 1():S62-S80. PubMed ID: 37317504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]